Risk factors for pancreatic adenocarcinoma and prospects for screening
- PMID: 20567579
- PMCID: PMC2886484
Risk factors for pancreatic adenocarcinoma and prospects for screening
Abstract
Pancreatic cancer has one of the worst survival rates of any cancer and is the fourth leading cause of cancer mortality. Early detection and surgery are the patient's best chance for cure. However, symptoms are typically vague and occur when the cancer is unresectable. Population-based mass screening is not practical for this rare disease, though screening and early detection in asymptomatic high-risk patient populations may be indicated.
Keywords: Pancreatic cancer; inherited risk factors; noninherited risk factors; screening.
References
-
- Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–130. - PubMed
-
- Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200–1210. - PubMed
-
- Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet. 2004;363:1049–1057. - PubMed
-
- Nakao A, Harada A, Nonami T, Kaneko T, Takagi H. Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas. 1996;12:357–361. - PubMed
LinkOut - more resources
Full Text Sources